Zdrowie i gospodarka · 17/12/2020

FDA Releases Final Guidance on Complex Innovative Trial Designs for Drugs and Biological Products

The Food and Drug Administration has released a final guidance document outlining recommendations for sponsors and applicants on interacting with the FDA on complex innovative trial design proposals for drugs and biological products, in response to a mandate under the 21st Century Cures Act.